PSMC2 and glioma: We found that the DDRRG signature, composed of FBXO18, MMS19, SMC4, HEXB, UBQLN4, VAV3, E2F7, EFNB1, WEE1, SAA1, SHISA5, WAC, PSMC2, PTGFRN, EIF3L and HMGA2, can independently predict the outcome of glioma patients.